High-Level Dialogue on

Paediatric HIV and TB in Children Living with HIV (ROME 5)

Virtual, 5-6 November 2020

High-Leve Dialogue (ROME 5)  - Concept

November 5, 2020

High-Level Dialogue on Paediatric HIV and TB in Children Living with HIV concept note.

High-Leve Dialogue (ROME 5) - Agenda

November 5, 2020

High-Level Dialogue on Paediatric HIV and TB in Children Living with HIV agenda.

Rome Action Plan Progress Report 2018-2020

November 5, 2020 - Opening Session

Presentation of  the 2018 ROME ACTION PLAN PROGRESS REPORT
December 2018 – November 2020

Rome Action Plan Progress Presentation

November 5, 2020 - Opening Session - Chip Lyons, EGPAF

Presentation of the Rome Action Plan Progress Report 2018-2020

HIV among children Status update

November 5, 2020 - Opening Session - Shannon Hader, UNAIDS

Status update on HIV among children

Challenges & Opportunities

November 5, 2020 - Session 1 TB - Blessina Kumar, GCTA

Challenges and Opportunities to address during High- Level Dialogue

TB in Children and Adolescents

November 5, 2020 - Session 1 TB- Dr. Tereza Kasaeva, WHO GTB

Presentation on TB in Children and Adolescents

Highlights Session 1TB

November 5, 2020 - Session 1 TB - Fr. Richard Bauer, EDARP

Highlights of Session 1

Scene Setter - R&D HIV Diagnostics for Children

November 5, 2020 - Session 2 R&D Diagnostics - Dr. Lara Vojnov, WHO

Setting the scene: Research & Development of HIV Diagnostics for Children

Scene Setter - TB Diangostics for Children

November 5, 2020 - Session 2 R&D Diagnostics - Dr. Nazir Ismail, WHO/GTB

Setting the scene: TB diagnostics for Children

Highlights Session 2 - R&D Diagnostics

November 5, 2020 - Session 2 R&D Diagnostics - Cheri Vincent, USAID

Highlights of Session 2

Scene Setter - R&D Medicines for Children

November 5, 2020 - Session 3 R&D Medicines - Lindsay McKenna, TAG

Setting the scene: Research & Development of TB Medicines for Children

Scene Setter - R&D Medicines for Children

November 5, 2020 - Session 3 R&D Medicines - Dr. Martina Penazzato, WHO

Setting the scene: Research & Development of Medicines for Children

Summary Day 1 & Overview Day 2

November 5, 2020 - Session 3 R&D Medicines - Dr. Meg Doherty, WHO

Summary of Day 1 and Overview of Day 2

Scene Setter - Identifying & Diagnosing Children

November 6, 2020 - Session 5 Identifying and Diagnosing Children - Jeff Lemaire, EGPAF

Setting the Scene on identifying and diagnosing children exposed to HIV and to TB

Scene Setter - Introduction & Scale-up Medicines for Children

November 6, 2020 - Session 6 Introduction and Scale-up of Medicines - Dr Brenda Waning, STBP

Setting the Scene on Introduction and Scale Up of TB Medicines for Children

Review of commitments on diagnostics and medicines

November 6, 2020 - Session 7 Commitments & Accountability - Dr Meg Doherty, WHO

Review of commitments on diagnostics and medicines

Accountability

November 6, 2020 - Session 7 Commitments & Accountability - Chip Lyons, EGPAF

Accountability Framework